相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent developments in limited stage small cell lung cancer
Kristin A. Higgins et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Altering DNA Repair to Improve Radiation Therapy: Specific and Multiple Pathway Targeting
Julian Biau et al.
FRONTIERS IN ONCOLOGY (2019)
Dual HDAC and PI3K Inhibition Abrogates NF kappa B- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas
Sharmistha Pal et al.
CANCER RESEARCH (2018)
Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
Vincent Ho et al.
BMC CANCER (2018)
Radiosensitivity enhancement of human thyroid carcinoma cells by the inhibitors of histone deacetylase sodium butyrate and valproic acid
Marina Perona et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
L. Horn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Targeting RAD50 increases sensitivity to radiotherapy in colorectal cancer cells
C. Chen et al.
NEOPLASMA (2018)
Targeting DNA damage repair in small cell lung cancer and the biomarker landscape
Triparna Sen et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
Unravelling the biology of SCLC: implications for therapy
Joshua K. Sabari et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Combination treatment of RAD001 and BEZ235 exhibits synergistic antitumor activity via down-regulation of p-4E-BP1/Mcl-1 in small cell lung cancer
Bo Hong et al.
ONCOTARGET (2017)
JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against MYCN-amplified small cell lung cancer
Huogang Wang et al.
ONCOTARGET (2017)
Small-cell lung cancer: what we know, what we need to know and the path forward (vol 17, pg 725, 2017)
Adi F. Gazdar et al.
NATURE REVIEWS CANCER (2017)
Antitumor activity and pharmacologic characterization of the depsipeptide analog as a novel histone deacetylase/ phosphatidylinositol 3-kinase dual inhibitor
Ken Saijo et al.
CANCER SCIENCE (2017)
Class I HDACs Affect DNA Replication, Repair, and Chromatin Structure: Implications for Cancer Therapy
Kristy R. Stengel et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma
Swaminathan P. Iyer et al.
ONCOLOGIST (2015)
Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair
B. Groselj et al.
BRITISH JOURNAL OF CANCER (2013)
Romidepsin (FK228) and its analogs directly inhibit phosphatidylinositol 3-kinase activity and potently induce apoptosis as histone deacetylase/phosphatidylinositol 3-kinase dual inhibitors
Ken Saijo et al.
CANCER SCIENCE (2012)
Inhibition of Histone Deacetylase in Cancer Cells Slows Down Replication Forks, Activates Dormant Origins, and Induces DNA Damage
Chiara Conti et al.
CANCER RESEARCH (2010)
Three-Dimensional Cell Growth Confers Radioresistance by Chromatin Density Modification
Katja Storch et al.
CANCER RESEARCH (2010)
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
Cliona Grant et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Phase II Study of the Histone Deacetylase Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30304)
Gregory A. Otterson et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
J-H. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Sensitization to γ-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells
Feng Zhang et al.
CANCER BIOLOGY & THERAPY (2009)
HDAC Inhibitor, Valproic Acid, Induces p53-Dependent Radiosensitization of Colon Cancer Cells
Xufeng Chen et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
The role of double-strand break repair - insights from human genetics
M O'Driscoll et al.
NATURE REVIEWS GENETICS (2006)
Modulation of radiation response by histone deacetylase inhibition
P Chinnaiyan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)amino-methyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells
Y Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors
Y Zhang et al.
RADIATION RESEARCH (2004)
Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines
J Tsurutani et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
分享论文
